Skip to content

DarioHealth Corp.: 10-Q filed 2019-10-28

What DarioHealth Corp. reported in its quarterly report filed 2019-10-28 (fiscal Q3 2019): 30 published measures, 88 facts as tagged in accession 0001104659-19-056644.

This filing

Form
10-Q (quarterly report)
Filed
2019-10-28
Fiscal period
fiscal Q3 2019
Accession
0001104659-19-056644 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All DarioHealth Corp. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2019-09-308,603,000USD
At 2018-12-3114,089,000USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2019-09-303,907,000USD
At 2019-06-306,094,000USD
At 2019-03-313,865,000USD
At 2018-12-318,925,000USD
At 2018-09-3010,411,000USD
At 2018-06-304,155,000USD
At 2018-03-317,371,000USD
At 2017-12-313,941,000USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2019-09-304,585,000USD
At 2018-12-3110,997,000USD
At 2018-09-3011,427,000USD
At 2017-12-313,718,000USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2019-07-01 to 2019-09-30-2,805,000USD92
2019-01-01 to 2019-09-30-13,563,000USD273
2019-04-01 to 2019-06-30-5,382,000USD91
2019-01-01 to 2019-03-31-5,376,000USD90
2018-07-01 to 2018-09-30-4,063,000USD92
2018-01-01 to 2018-09-30-12,820,000USD273
2018-04-01 to 2018-06-30-5,838,000USD91
2018-01-01 to 2018-03-31-2,919,000USD90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2019-01-01 to 2019-09-30-12,873,000USD273
2018-01-01 to 2018-09-30-8,031,000USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2019-01-01 to 2019-09-3079,000USD273
2018-01-01 to 2018-09-3049,000USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2019-01-01 to 2019-09-306,558,000USD273
2018-01-01 to 2018-09-3015,720,000USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2019-01-01 to 2019-09-30-97,000USD273
2018-01-01 to 2018-09-3020,000USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2019-09-30-102,817,000USD
At 2018-12-31-89,254,000USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2019-09-30674,000USD
At 2018-12-31733,000USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2019-07-01 to 2019-09-30-2,799,000USD92
2019-01-01 to 2019-09-30-13,524,000USD273
2018-07-01 to 2018-09-30-4,054,000USD92
2018-01-01 to 2018-09-30-12,762,000USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2019-09-307,158,000USD
At 2018-12-3113,313,000USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2019-09-304,219,000USD
At 2018-12-315,164,000USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2019-07-01 to 2019-09-303,672,000USD92
2019-01-01 to 2019-09-3015,281,000USD273
2018-07-01 to 2018-09-304,522,000USD92
2018-01-01 to 2018-09-3014,304,000USD273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2019-09-301,473,000USD
At 2018-12-311,377,000USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2019-07-01 to 2019-09-30873,000USD92
2019-01-01 to 2019-09-301,757,000USD273
2018-07-01 to 2018-09-30468,000USD92
2018-01-01 to 2018-09-301,542,000USD273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2019-07-01 to 2019-09-30859,000USD92
2019-01-01 to 2019-09-302,852,000USD273
2018-07-01 to 2018-09-30997,000USD92
2018-01-01 to 2018-09-302,749,000USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2019-09-3043,683,840shares
At 2018-12-3136,607,755shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2019-09-30106,716,000USD
At 2018-12-3198,171,000USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2019-09-30719,000USD
At 2018-12-310USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2019-09-30764,000USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2019-09-30392,000USD
At 2018-12-31591,000USD

Current contract liabilities

Consideration received before performance obligations are satisfied, often called deferred revenue. It is an obligation to deliver, not earned revenue or cash available.

PeriodValueUnitDays
At 2019-09-301,311,000USD
At 2018-12-31736,000USD

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2019-07-01 to 2019-09-30-2,805,000USD92
2019-01-01 to 2019-09-30-13,563,000USD273
2018-07-01 to 2018-09-30-4,063,000USD92
2018-01-01 to 2018-09-30-13,313,000USD273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2019-07-01 to 2019-09-30948,000USD92
2019-01-01 to 2019-09-303,625,000USD273
2018-07-01 to 2018-09-30709,000USD92
2018-01-01 to 2018-09-304,506,000USD273

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2019-01-01 to 2019-09-30138,000USD273
2018-01-01 to 2018-09-30160,000USD273

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2019-07-01 to 2019-09-30-6,000USD92
2019-01-01 to 2019-09-30-39,000USD273
2018-07-01 to 2018-09-30-9,000USD92
2018-01-01 to 2018-09-30-59,000USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2019-07-01 to 2019-09-30-6,000USD92
2019-01-01 to 2019-09-30-39,000USD273
2018-07-01 to 2018-09-30-9,000USD92
2018-01-01 to 2018-09-30-58,000USD273

Operating lease payments

Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.

PeriodValueUnitDays
2019-01-01 to 2019-09-30230,000USD273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2019-01-01 to 2019-09-3096,000USD273
2018-01-01 to 2018-09-30-164,000USD273

Inspect the source

Entity
DarioHealth Corp. / CIK 0001533998
Captured
2026-09-20T09:16:34.053Z
SEC response SHA-256
8c524c61fa46c2531eea7286cfb0614b41c397fc0b2f416d3e5df141148eb6b9

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001533998.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))